Mechanisms and effects of NLRP3 in digestive cancers

Yuxin Si,Lei Liu,Zhe Fan

DOI: https://doi.org/10.1038/s41420-023-01783-6

2024-01-06

Cell Death Discovery

Abstract:Inflammasomes are thought to be important mediators of host defense against microbial pathogens and maintenance of gastrointestinal tract homeostasis. They can modulate caspase-1 to promote IL-18 and IL-1β secretion and promote phagocytosis induced by bacterial pathogens. NLRP3 is an inflammasome comprising a multiprotein complex assembled by pattern recognition receptors in the cell cytoplasm. It is a crucial component of the innate immune system. Dysregulation of NLRP3 may contribute to inflammatory diseases and intestinal cancers. Recent research suggests that NLRP3 plays an essential role in tumor development; therefore, intensive study of its mechanism is warranted as it could play a key role in the treatment of digestive system tumors. In this review, we discuss the mechanism and role of NLRP3 in tumors of the digestive system and response strategies to modulate NLRP3 for potential use in tumor treatment.

cell biology

What problem does this paper attempt to address?

The paper primarily explores the mechanisms of action of the NLRP3 inflammasome in digestive system cancers and its impact on tumor occurrence and development. NLRP3 is a multiprotein complex assembled by pattern recognition receptors in the cytoplasm and is an important component of the innate immune system. Its dysfunction may be associated with inflammatory diseases and intestinal cancers.

The paper focuses on the role of NLRP3 in several digestive system cancers:
1. **Colorectal Cancer (CRC)**: The role of NLRP3 may be dual-sided. On one hand, it inhibits tumor metastasis by activating IL-18 and IL-1β; on the other hand, it may promote tumor cell migration and invasion. A high-cholesterol diet increases the inflammatory response and tumor burden by activating the NLRP3 inflammasome in macrophages, thereby promoting the occurrence of CRC.
2. **Gastric Cancer**: Helicobacter pylori infection leads to the migration and invasion of gastric cancer cells by activating the NLRP3 inflammasome pathway. Additionally, the CagA protein can promote the invasion and migration of gastric cancer cells by activating the NLRP3 inflammasome and the generation of intracellular reactive oxygen species (ROS).
3. **Liver Cancer**: The expression level of the NLRP3 inflammasome is lower in liver cancer tissues and is negatively correlated with the pathological grade and clinical stage of patients, suggesting that the NLRP3 inflammasome may have a protective role in the progression of liver cancer.
4. **Pancreatic Cancer**: High expression of the NLRP3 inflammasome is associated with poor survival and prognosis in patients. Studies have found that interfering with platelet NLRP3 signaling can significantly improve the survival rate of tumor-bearing mice, indicating that the platelet NLRP3 inflammasome plays a key role in pancreatic cancer.

In summary, this paper aims to elucidate the complex mechanisms of action of the NLRP3 inflammasome in different digestive system cancers and explore its potential as a therapeutic target.